These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Marrow-ablative treatment and autologous stem cell transplantation in follicular NHL. Bachy E; Salles G Best Pract Res Clin Haematol; 2011 Jun; 24(2):257-70. PubMed ID: 21658622 [TBL] [Abstract][Full Text] [Related]
4. Treatment strategies in advanced stage follicular lymphoma. van Oers MH; Kersten MJ Best Pract Res Clin Haematol; 2011 Jun; 24(2):187-201. PubMed ID: 21658618 [TBL] [Abstract][Full Text] [Related]
5. Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study. Sebban C; Brice P; Delarue R; Haioun C; Souleau B; Mounier N; Brousse N; Feugier P; Tilly H; Solal-Céligny P; Coiffier B J Clin Oncol; 2008 Jul; 26(21):3614-20. PubMed ID: 18559872 [TBL] [Abstract][Full Text] [Related]
6. Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma. Boland A; Bagust A; Hockenhull J; Davis H; Chu P; Dickson R Health Technol Assess; 2009 Sep; 13 Suppl 2():41-8. PubMed ID: 19804688 [TBL] [Abstract][Full Text] [Related]
7. Rituximab maintenance therapy for follicular lymphoma: no better than watchful waiting. Prescrire Int; 2012 Mar; 21(125):62. PubMed ID: 22428182 [TBL] [Abstract][Full Text] [Related]
8. Rituximab in autologous stem cell transplantation for follicular lymphoma. Schmitz N Anticancer Drugs; 2001 Jun; 12 Suppl 2():S21-4. PubMed ID: 11508933 [TBL] [Abstract][Full Text] [Related]
9. Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma. Lazzarino M; Arcaini L; Orlandi E; Iacona I; Bernasconi P; Calatroni S; Varettoni M; Isa L; Brusamolino E; Bonfichi M; Passamonti F; Burcheri S; Pascutto C; Regazzi M Oncology; 2005; 68(2-3):146-53. PubMed ID: 16006752 [TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
11. Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab: a multicenter phase II study. Tobinai K; Igarashi T; Itoh K; Kurosawa M; Nagai H; Hiraoka A; Kinoshita T; Uike N; Ogura M; Nawano S; Mori S; Ohashi Y; Cancer Sci; 2011 Sep; 102(9):1698-705. PubMed ID: 21645173 [TBL] [Abstract][Full Text] [Related]
12. Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Barosi G; Carella A; Lazzarino M; Marchetti M; Martelli M; Rambaldi A; Tarella C; Vitolo U; Zinzani PL; Tura S; ; ; Haematologica; 2006 Jan; 91(1):96-103. PubMed ID: 16434377 [TBL] [Abstract][Full Text] [Related]
13. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma. Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026 [TBL] [Abstract][Full Text] [Related]
14. Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study. Askeland G Expert Rev Clin Immunol; 2013 May; 9(5):402. PubMed ID: 23772446 [No Abstract] [Full Text] [Related]
16. Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation. Puig N; Caballero MD; Alcoceba M; Sebastián E; Balanzategui A; Sarasquete ME; García-Sanz R; González-Díaz M Ann Hematol; 2011 Feb; 90(2):227-9. PubMed ID: 20506021 [No Abstract] [Full Text] [Related]
17. Role of hematopoietic stem cell transplant in the management of follicular lymphoma. Foster M; Gabriel DA; Shea T Oncologist; 2009 Jul; 14(7):726-38. PubMed ID: 19561292 [TBL] [Abstract][Full Text] [Related]
19. Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescue. Hohloch K; Sahlmann CO; Lakhani VJ; Wulf G; Glass B; Hasenkamp J; Meller J; Riggert J; Trümper L; Griesinger F Ann Hematol; 2011 Nov; 90(11):1307-15. PubMed ID: 21360108 [TBL] [Abstract][Full Text] [Related]